← Back to home

PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA)

Clinical trials for PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA) explained in plain language.

Never miss a new study

Get alerted when new PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA) trials appear

Sign up with your email to follow new studies for PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Drug safety check: tracking side effects in new leukemia patients

Disease control Completed

This study monitored the safety of Calquence (acalabrutinib) in real-world patients with previously untreated chronic lymphocytic leukemia. It tracked how often side effects like infections and low blood counts occurred after the drug was approved for this use. The goal was to un…

Matched conditions: PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA)

Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA)

Get alerted when new PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA) trials appear

Drug safety check: tracking side effects in new leukemia patients